Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001178913-22-000265
Filing Date
2022-01-31
Accepted
2022-01-31 07:16:56
Documents
1
Group Members
ANGELS INVESTMENTS IN HI TECH LTD

Document Format Files

Seq Description Document Type Size
1 SC 13G/A zk2227148.htm SC 13G/A 98286
  Complete submission text file 0001178913-22-000265.txt   99802
Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-50118 | Film No.: 22571299
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 18 YEHEZKEL ST TEL AVIV-YAFO L3 6259524
Business Address
NACHT MARIUS (Filed by) CIK: 0001218503 (see all company filings)

Type: SC 13G/A